Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity.
Kou KanesadaRyouichi TsunedomiShoichi HazamaHiroyuki OgiharaYoshihiko HamamotoYoshitaro ShindoHiroto Matsui MatsuiYukio TokumitsuShin YoshidaMichihisa IidaNobuaki SuzukiShigeru TakedaTatsuya IokaHiroaki NaganoPublished in: Cancer medicine (2022)
Thus, an SNP in the R3HCC1 gene may be a useful biomarker for the toxicity of irinotecan-containing chemotherapy for mCRC and pancreatic cancer.